Kane, J. M., Eshet, R., Harary, E., Tohami, O., Elgart, A., Knebel, H., . . . Correll, C. U. (2024). A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia. CNS Drugs, 1-12. https://doi.org/10.1007/s40263-024-01102-2
Chicago-referens (17:e uppl.)Kane, John M., et al. "A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia." CNS Drugs 2024: 1-12. https://doi.org/10.1007/s40263-024-01102-2.
MLA-referens (9:e uppl.)Kane, John M., et al. "A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia." CNS Drugs, 2024, pp. 1-12, https://doi.org/10.1007/s40263-024-01102-2.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
